Abbott director granted 76 stock equivalent units
Alpern Robert J reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Alpern Robert J reported acquisition or exercise transactions in this Form 4 filing.
ABBOTT LABORATORIES director Robert J. Alpern received a grant of 76 stock equivalent units on March 31, 2026 as part of his director compensation. These units are valued at $102.67 per unit and track the return of Abbott common shares.
The units are credited to a stock equivalent unit account in a grantor trust established by the director and are generally paid out in cash at age 65 or upon retirement from the board. After this award and dividend reinvestment activity, his balance totals 10,544 stock equivalent units in this account.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Equivalent Units | 76 | $102.67 | $8K |
Footnotes (2)
- F1. Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.
- F2. Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.
Key Figures
Key Terms
Stock Equivalent Units financial
grantor trust financial
dividend reinvestment feature financial
FAQ
What did Abbott Laboratories (ABT) disclose in this Form 4 for director Robert J. Alpern?
How many stock equivalent units does Robert J. Alpern hold after this Abbott (ABT) transaction?
Was this Abbott (ABT) Form 4 an open-market stock purchase or sale?
How are the Abbott (ABT) stock equivalent units for Robert J. Alpern valued?
When will Robert J. Alpern receive cash for these Abbott (ABT) stock equivalent units?
AI-generated analysis. How Rhea-AI works. Not financial advice.